These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28415763)

  • 41. DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4.
    Bardini M; Spinelli R; Bungaro S; Mangano E; Corral L; Cifola I; Fazio G; Giordan M; Basso G; De Rossi G; Biondi A; Battaglia C; Cazzaniga G
    Leukemia; 2010 Jan; 24(1):169-76. PubMed ID: 19907438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosome translocations and covert leukemic clones are generated during normal fetal development.
    Mori H; Colman SM; Xiao Z; Ford AM; Healy LE; Donaldson C; Hows JM; Navarrete C; Greaves M
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8242-7. PubMed ID: 12048236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
    He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
    Stumpel DJ; Schneider P; Seslija L; Osaki H; Williams O; Pieters R; Stam RW
    Leukemia; 2012 Apr; 26(4):682-92. PubMed ID: 22015773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
    Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
    Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia.
    Elia L; Mancini M; Moleti L; Meloni G; Buffolino S; Krampera M; De Rossi G; Foà R; Cimino G
    Haematologica; 2003 Mar; 88(3):275-9. PubMed ID: 12651265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.
    Teppo S; Laukkanen S; Liuksiala T; Nordlund J; Oittinen M; Teittinen K; Grönroos T; St-Onge P; Sinnett D; Syvänen AC; Nykter M; Viiri K; Heinäniemi M; Lohi O
    Genome Res; 2016 Nov; 26(11):1468-1477. PubMed ID: 27620872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
    Rubnitz JE
    J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of low-dose ionizing radiation on genomic instability in interventional radiology workers.
    Kochanova D; Gulati S; Durdik M; Jakl L; Kosik P; Skorvaga M; Vrobelova K; Vigasova K; Markova E; Salat D; Klepanec A; Belyaev I
    Sci Rep; 2023 Sep; 13(1):15525. PubMed ID: 37726322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.
    Hein D; Dreisig K; Metzler M; Izraeli S; Schmiegelow K; Borkhardt A; Fischer U
    Blood; 2019 Oct; 134(16):1355-1358. PubMed ID: 31434706
    [No Abstract]   [Full Text] [Related]  

  • 53. Diet as a Potential Moderator for Genome Stability and Immune Response in Pediatric Leukemia.
    Wang S; Maxwell CA; Akella NM
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization.
    Tasdogan A; Kumar S; Allies G; Bausinger J; Beckel F; Hofemeister H; Mulaw M; Madan V; Scharffetter-Kochanek K; Feuring-Buske M; Doehner K; Speit G; Stewart AF; Fehling HJ
    Cell Stem Cell; 2017 Mar; 20(3):415. PubMed ID: 28257711
    [No Abstract]   [Full Text] [Related]  

  • 55. Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia.
    Basilico S; Göttgens B
    J Mol Med (Berl); 2017 Jul; 95(7):719-727. PubMed ID: 28429049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.
    Micol JB; Pastore A; Inoue D; Duployez N; Kim E; Lee SC; Durham BH; Chung YR; Cho H; Zhang XJ; Yoshimi A; Krivtsov A; Koche R; Solary E; Sinha A; Preudhomme C; Abdel-Wahab O
    Nat Commun; 2017 May; 8():15429. PubMed ID: 28516957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
    Vu LP; Prieto C; Amin EM; Chhangawala S; Krivtsov A; Calvo-Vidal MN; Chou T; Chow A; Minuesa G; Park SM; Barlowe TS; Taggart J; Tivnan P; Deering RP; Chu LP; Kwon JA; Meydan C; Perales-Paton J; Arshi A; Gönen M; Famulare C; Patel M; Paietta E; Tallman MS; Lu Y; Glass J; Garret-Bakelman FE; Melnick A; Levine R; Al-Shahrour F; Järås M; Hacohen N; Hwang A; Garippa R; Lengner CJ; Armstrong SA; Cerchietti L; Cowley GS; Root D; Doench J; Leslie C; Ebert BL; Kharas MG
    Nat Genet; 2017 Jun; 49(6):866-875. PubMed ID: 28436985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
    Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
    Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal and Neoplastic Stem Cells.
    McCracken MN; George BM; Kao KS; Marjon KD; Raveh T; Weissman IL
    Cold Spring Harb Symp Quant Biol; 2016; 81():1-9. PubMed ID: 28416577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parental occupational exposure to combustion products, metals, silica and asbestos and risk of childhood leukaemia: Findings from the Childhood Cancer and Leukaemia International Consortium (CLIC).
    Onyije FM; Olsson A; Erdmann F; Magnani C; Petridou E; Clavel J; Miligi L; Bonaventure A; Ferrante D; Piro S; Peters S; Vermeulen R; Kromhout H; Schüz J;
    Environ Int; 2022 Sep; 167():107409. PubMed ID: 35908390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.